A single dose of Covishield vaccine induced high neutralizing antibody and T cell responses - Sri Lankan study

A study in Sri Lanka has found that 93.4% individuals developed antibodies to a single dose of the Covishield vaccine, the made-in-India variant of Oxford-AstraZeneca s AZD-1222 formulation, while 97.1% developed neutralizing antibodies. MORE..

from AdaDerana RSS https://ift.tt/3fdUTJV
https://ift.tt/3zTc4Zm